During the past decade, Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie; Klinika Neurologii conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie; Klinika Neurologii" are "Chronic Inflammatory Demyelinating Poly(Radiculo)Neuropathy" (1 trials) and "Neuromyelitis Optica Spectrum Disorder" (1 trials). Many other conditions were trialed in "Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie; Klinika Neurologii" in a lesser frequency.

Most popular intervention types in "Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie; Klinika Neurologii" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "NewGam" (1 trials), "azathioprine (AZA)" (1 trials), "mycophenolate mofetil (MMF)" (1 trials), "oral corticosteroids" (1 trials) and "satralizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie; Klinika Neurologii" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie; Klinika Neurologii". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie; Klinika Neurologii, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie; Klinika Neurologii, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".